Cargando…

Nanobody Based Dual Specific CARs

Recent clinical trials have shown that adoptive chimeric antigen receptor (CAR) T cell therapy is a very potent and possibly curative option in the treatment of B cell leukemias and lymphomas. However, targeting a single antigen may not be sufficient, and relapse due to the emergence of antigen nega...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Munter, Stijn, Ingels, Joline, Goetgeluk, Glenn, Bonte, Sarah, Pille, Melissa, Weening, Karin, Kerre, Tessa, Abken, Hinrich, Vandekerckhove, Bart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855625/ https://www.ncbi.nlm.nih.gov/pubmed/29385713 http://dx.doi.org/10.3390/ijms19020403

Ejemplares similares

Rapid and Effective Generation of Nanobody Based CARs using PCR and Gibson Assembly
por: De Munter, Stijn, et al.
Publicado: (2020)

T-cells with a single tumor antigen-specific T-cell receptor can be generated in vitro from clinically relevant stem cell sources
por: Bonte, Sarah, et al.
Publicado: (2020)

In vitro OP9-DL1 co-culture and subsequent maturation in the presence of IL-21 generates tumor antigen-specific T cells with a favorable less-differentiated phenotype and enhanced functionality
por: Bonte, Sarah, et al.
Publicado: (2021)

Human Thymic CD10(+) PD-1(+) Intraepithelial Lymphocyte Precursors Acquire Interleukin-15 Responsiveness at the CD1a(–) CD95(+) CD28(–) CCR7(–) Developmental Stage
por: Billiet, Lore, et al.
Publicado: (2020)

Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities
por: Van Caeneghem, Yasmine, et al.
Publicado: (2017)

The Wiskott–Aldrich syndrome protein is required for positive selection during T-cell lineage differentiation
por: Pille, Melissa, et al.
Publicado: (2023)

Single-cell profiling identifies a novel human polyclonal unconventional T cell lineage
por: Billiet, Lore, et al.
Publicado: (2023)

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment
por: Depreter, Barbara, et al.
Publicado: (2020)

Can immunotherapy specifically target acute myeloid leukemic stem cells?
por: Snauwaert, Sylvia, et al.
Publicado: (2013)

CAR T Cells: A Snapshot on the Growing Options to Design a CAR
por: Holzinger, Astrid, et al.
Publicado: (2019)

CAR T cell therapy becomes CHIC: “cytokine help intensified CAR” T cells
por: Thomas, Simone, et al.
Publicado: (2023)

CAR's made it to the pancreas
por: Chmielewski, Markus, et al.
Publicado: (2012)

Do Treg Speed Up with CARs? Chimeric Antigen Receptor Treg Engineered to Induce Transplant Tolerance
por: Kaljanac, Marcell, et al.
Publicado: (2022)

The Application of Nanobody in CAR-T Therapy
por: Bao, Chaolemeng, et al.
Publicado: (2021)

Dendritic Cell-Based Immunotherapy in Lung Cancer
por: Stevens, Dieter, et al.
Publicado: (2021)

Most Do, but Some Do Not: CD4(+)CD25(−) T Cells, but Not CD4(+)CD25(+) Treg Cells, Are Cytolytic When Redirected by a Chimeric Antigen Receptor (CAR)
por: Hombach, Andreas A., et al.
Publicado: (2017)

IRF4 downregulation improves sensitivity and endurance of CAR T cell functional capacities
por: Harrer, Dennis Christoph, et al.
Publicado: (2023)

Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-Specific CAR-T Cells
por: Harrer, Dennis Christoph, et al.
Publicado: (2022)

Nanobody-based CAR-T cells for cancer immunotherapy
por: Safarzadeh Kozani, Pouya, et al.
Publicado: (2022)

A CD19-Anti-ErbB2 scFv Engager Protein Enables CD19-Specific CAR T Cells to Eradicate ErbB2(+) Solid Cancer
por: Hombach, Andreas A., et al.
Publicado: (2023)

The human fetal thymus generates invariant effector γδ T cells
por: Tieppo, Paola, et al.
Publicado: (2019)

Young T Cells Age During a Redirected Anti-Tumor Attack: Chimeric Antigen Receptor-Provided Dual Costimulation is Half the Battle
por: Hombach, Andreas A., et al.
Publicado: (2013)

Intracellular Delivery of mRNA in Adherent and Suspension Cells by Vapor Nanobubble Photoporation
por: Raes, Laurens, et al.
Publicado: (2020)

CAR Triggered Release of Type-1 Interferon Limits CAR T-Cell Activities by an Artificial Negative Autocrine Loop
por: Harrer, Dennis Christoph, et al.
Publicado: (2022)

A Small Number of HER2 Redirected CAR T Cells Significantly Improves Immune Response of Adoptively Transferred Mouse Lymphocytes against Human Breast Cancer Xenografts
por: Tóth, Gábor, et al.
Publicado: (2020)

CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma
por: Ciulean, Ioana Sonya, et al.
Publicado: (2023)

IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells
por: Hombach, Andreas A., et al.
Publicado: (2020)

Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T Cells
por: Chmielewski, Markus, et al.
Publicado: (2013)

Building on Synthetic Immunology and T Cell Engineering: A Brief Journey Through the History of Chimeric Antigen Receptors
por: Abken, Hinrich
Publicado: (2021)

S80. Prolongation of T cell response by OX40 co-signalling CARS
por: Abken, H
Publicado: (2014)

IL12 integrated into the CAR exodomain converts CD8(+) T cells to poly-functional NK-like cells with superior killing of antigen-loss tumors
por: Hombach, Andreas, et al.
Publicado: (2022)

Preclinical development and evaluation of nanobody-based CD70-specific CAR T cells for the treatment of acute myeloid leukemia
por: Cheng, Jiali, et al.
Publicado: (2023)

Photothermal nanofibers enable safe engineering of therapeutic cells
por: Xiong, Ranhua, et al.
Publicado: (2021)

Evolution of nanobodies specific for BCL11A
por: Yin, Maolu, et al.
Publicado: (2023)

Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
por: Wang, Hongxia, et al.
Publicado: (2021)

Expression of TRX1 optimizes the antitumor functions of human CAR T cells and confers resistance to a pro-oxidative tumor microenvironment
por: Balta, Emre, et al.
Publicado: (2022)

Cas9 RNP transfection by vapor nanobubble photoporation for ex vivo cell engineering
por: Raes, Laurens, et al.
Publicado: (2021)

The beating heart of melanomas: a minor subset of cancer cells sustains tumor growth
por: Schmidt, Patrick, et al.
Publicado: (2011)

Chimeric antigen receptors designed to overcome transforming growth factor‐β‐mediated repression in the adoptive T‐cell therapy of solid tumors
por: Hartley, Jordan, et al.
Publicado: (2019)

CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation
por: Barden, Markus, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vcppmen1bns2jfg88ig6uq51sn